Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Prompted by increased reports of syncope, the FDA has announced the withdrawal of the liquid formulation of the growth factor sargramostim (Leukine). References and Resources FDA Warns Physicians…
Joseph Minniti, Founder and Director, The Cancer Foundation for Personal Appearance Inc, demonstrates how wigs and other hair attachments can help those suffering from hair loss due to…
Joseph Minniti, Founder and Director, The Cancer Foundation for Personal Appearance Inc, discusses how his business provides education, guidance, hair replacements, and wigs to help support women living…
Jie Yang, DDS, Associate Professor/Director of Radiology, Oral Maxillofacial Pathology Medicine and Surgery, Kornberg School of Dentistry, Temple University, discusses new advances in dental radiology. References and Resources…
John Travaline, MD, Associate Professor of Medicine, Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses lung cancer screening. References and Resources National Cancer Institute Lung…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses breast cancer support. References and Resources…
Howard Simon, MD, Director, Newly Invasive and Bariatric Surgery, State University Hospital Syracuse, discusses adrenal masses. References and Resources Pacak, K., Eisenhofer, G., Grossman, A., Gavras, I. The…
This study discusses four serum proteins: carcinoembryonic antigen, retinol binding protein, alpha1-antitrypsin, and squamous cell carcinoma antigen, and how they were collectively found to correctly classify the majority…
Scientists suspect that overnight work is dangerous because it disrupts the circadian rhythm, and is a potential cause of breast and prostate cancer. References and Resources Stevens RG,…
